Romualdez, Boben T.
HRN: 23-49-49 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/11/2023
CEFUROXIME 1.5GM (VIAL)
08/11/2023
08/17/2023
IV
1.5g
Q8
UTI; PCAP B
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes